Literature DB >> 3929248

On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors.

C A Rouzer, B Samuelsson.   

Abstract

Arachidonate 5-lipoxygenase was purified 400-fold from homogenates of human peripheral blood leukocytes by a combination of ammonium sulfate fractionation, gel filtration chromatography, and HPLC on anion exchange and hydroxylapatite columns. NaDodSO4/polyacrylamide gel electrophoresis of the purified protein revealed the presence of a single major band (apparent Mr, 80,000). Densitometric analysis of the Coomassie blue staining pattern of the gels revealed that a 90-97% purity had been achieved. As has been reported for the 5-lipoxygenase from other mammalian sources, the human leukocyte enzyme required Ca2+ and ATP for maximal activity. In addition, a number of factors were isolated during the course of the purification, which possessed significant 5-lipoxygenase stimulatory activities. These were obtained in a high-speed pellet of leukocyte homogenate, a 60-90% ammonium sulfate precipitate fraction, and the unabsorbed protein from the first anion exchange HPLC step. In the absence of stimulatory factors, little activity was detected in the purified enzyme, even in the presence of Ca2+ and ATP. The specific function of these various factors is unknown, but their existence suggests that the human leukocyte 5-lipoxygenase is regulated by a complex mechanism that is likely to play an important role in the control of leukotriene and lipoxin biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929248      PMCID: PMC390695          DOI: 10.1073/pnas.82.18.6040

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.

Authors:  L Orning; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

4.  Calcium stimulation of a novel lipoxygenase.

Authors:  B A Jakschik; F F Sun; L Lee; M M Steinhoff
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

5.  Calcium stimulation of the 5-lipoxygenase from RBL-1 cells.

Authors:  C W Parker; S Aykent
Journal:  Biochem Biophys Res Commun       Date:  1982-12-15       Impact factor: 3.575

6.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

7.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

8.  Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

10.  Leukotriene A4 hydrolase in human leukocytes. Purification and properties.

Authors:  O Rådmark; T Shimizu; H Jörnvall; B Samuelsson
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

View more
  40 in total

Review 1.  Regulation of expression of the 5-lipoxygenase pathway.

Authors:  T D Bigby
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Molecular cloning and amino acid sequence of human 5-lipoxygenase.

Authors:  T Matsumoto; C D Funk; O Rådmark; J O Höög; H Jörnvall; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Role of prostaglandins and leukotrienes in volume regulation by Ehrlich ascites tumor cells.

Authors:  I H Lambert; E K Hoffmann; P Christensen
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

4.  Kinetic and structural investigations into the allosteric and pH effect on the substrate specificity of human epithelial 15-lipoxygenase-2.

Authors:  Netra Joshi; Eric K Hoobler; Steven Perry; Giovanni Diaz; Brian Fox; Theodore R Holman
Journal:  Biochemistry       Date:  2013-10-30       Impact factor: 3.162

5.  Characterization of the human 5-lipoxygenase gene.

Authors:  C D Funk; S Hoshiko; T Matsumoto; O Rdmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase.

Authors:  C A Rouzer; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation.

Authors:  D Riendeau; D Denis; L Y Choo; D J Nathaniel
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

8.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

9.  Arachidonic acid metabolism in cultured adult myocardial cells under short-time hypoxic conditions.

Authors:  B Härtel; R Morwinski; D Heydeck; B Papies
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

10.  Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4.

Authors:  B K Lam; K Xu; M B Atkins; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.